查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2003132

獸用免疫診斷試劑市場：2026-2032年全球市場預測（按產品類型、技術、目標動物、通路、應用和最終用戶分類）

Veterinary Immunodiagnostics Market by Product Type, Technology, Animal Type, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸醫免疫診斷市場價值將達到 15.4 億美元，到 2026 年將成長到 16.7 億美元，到 2032 年將達到 27.4 億美元，複合年成長率為 8.51%。

主要市場統計數據
基準年 2025 15.4億美元
預計年份：2026年 16.7億美元
預測年份 2032 27.4億美元
複合年成長率 (%) 8.51%

全面概述了技術創新、臨床需求和實際情況如何融合，從而重新定義獸醫免疫診斷。

獸醫免疫診斷正處於一個轉折點，科學進步與不斷變化的臨床需求在此交匯，重塑著我們檢測、管理和預防動物疾病的方式。過去十年，診斷平台已從單一檢查室的工作流程轉向更整合、自動化和響應迅速的系統，從而能夠在各種臨床環境中做出及時的臨床決策。因此，獸醫、診斷檢查室和研究機構越來越重視免疫診斷解決方案，不再僅僅將其視為試劑和儀器，而是將其視為更廣泛的醫療保健生態系統的組成部分，該生態系統還包括數據分析、照護現場能力和供應鏈管理。

快速檢測創新、工作流程自動化和不斷發展的分銷模式如何共同重塑獸醫免疫診斷的未來。

獸醫免疫診斷領域正經歷著變革性的轉變，這主要得益於技術、臨床和商業性趨勢的整合。檢測方法和檢測平台的化學基礎的快速發展提高了分析靈敏度和處理能力，從而能夠更早、更準確地檢測疾病。同時，自動化和整合儀器的興起減少了人工操作所需的時間和操作誤差。這使得診斷服務能夠從專業實驗室擴展到分散的臨床機構。因此，產品設計越來越重視工作流程效率、可重複性和與數位化報告系統的兼容性。

2025 年美國關稅措施對營運和採購的影響，以及產業相關人員如何調整其採購和定價策略。

美國2025年實施的關稅政策，對獸醫免疫診斷供應鏈的採購、籌資策略和成本結構產生了影響，並引發了一系列新的貿易考量。依賴跨境供應儀器、試劑和檢測組件的製造商和經銷商被迫重新評估供應商協議、庫存政策和供應商多元化策略，以維持服務的連續性。因此，採購團隊加快了供應商合格流程，並更加重視多供應商框架，以降低單點故障（SPOF）的風險。

解讀產品、技術、目標動物物種、分銷、應用和最終用戶細分，為優先產品開發和商業化策略提供資訊。

セグメンテーションを詳細に理解することで、多様な臨床的および運用上のニーズを満たすために、製品開発と商業化の取り組みをどこに集中させるべきかが明らかになります。市場を製品タイプという観点から捉えると、主に3つのカテゴリーが浮かび上がります。それは、免疫檢測キット、機器、および試薬です。免疫檢測キットには、化學冷光免疫檢測キット、ELISAキット、螢光免疫分析法キット、橫向流動化驗キット、およびラジオ免疫測量キットが含まれ、それぞれがハイスループットな実験室検査から迅速な照護現場篩檢に至るまで、異なる使用事例に対応しています。機器には、自動免疫檢測システム、化學冷光システム、ルミノメーター、微孔盤リーダーなどが含まれ、処理能力、自動化、分析能力のバランスがそれぞれ異なります。試薬には抗原や抗体に加え、バッファーや溶液などが含まれます。これらはアッセイ性能の基盤となるものであり、一貫した品管が求められます。

美洲、歐洲、中東和非洲以及亞太地區在競爭力和需求方面的區域差異，影響著我們的目標市場策略和產品在地化。

區域趨勢指南市場進入和擴大策略提供了獨特的機會和營運考慮。在美洲，成熟的檢查室網路和強大的私人獸醫行業推動了對高性能檢測設備和檢驗的檢測試劑盒的需求。這種環境有利於能夠提供強大的技術支援、合規性保障以及滿足伴侶動物照護和大規模畜牧養殖需求的綜合服務模式的供應商。相較之下，歐洲、中東和非洲地區的管理體制和基礎設施能力差異很大。在這些地區，市場參與企業必須滿足各種不同的合規要求，同時設計出既能適應高度監管市場又能適應檢測能力有限地區的解決方案。戰略夥伴關係和區域銷售協議通常在實現全部區域發揮著至關重要的作用。

產品組合深度、創新速度、策略聯盟以及由高價值服務模式驅動的競爭動態決定了市場定位和成長軌跡。

獸醫免疫診斷領域的競爭動態融合了成熟跨國診斷公司的優勢、高度專業化的創新者的敏捷性以及獸醫服務供應商的專業知識。主要企業通常憑藉包含儀器、檢驗的檢測試劑盒和可靠試劑供應的全面產品組合脫穎而出，並投資於品質保證和法規遵從性，以支持臨床應用。同時，規模小規模、更靈活的公司則專注於就地檢驗、新型化學方法或專有的物種特異性診斷，這通常使它們能夠更快地檢驗創新方法並滿足特定應用需求。

為加速在各種獸醫環境中採用技術、加強供應鏈、協調檢驗流程和擴大商業性覆蓋範圍，提出切實可行的策略建議。

在瞬息萬變的環境中，產業領導企業應推動一系列切實可行的舉措，以創造價值並降低營運風險。首先，應優先投資於兼顧分析性能和工作流程效率的檢測平台和儀器，確保產品能夠滿足集中式檢查室和分散式臨床環境的需求。這將透過使檢驗策略與監管預期和最終用戶使用案例保持一致，加速臨床應用和產品整合到治療流程中。其次，應透過供應商多元化、區域製造夥伴關係以及健全的品質系統來增強供應鏈韌性，從而減輕貿易中斷的影響，並維持試劑的穩定供應。

採用透明、多方面的研究途徑，結合專家直接參與、檢查室驗證審查和系統性的次要分析，以確保獲得可靠的見解。

本分析採用透明、多面向的研究方法整合證據，旨在確保其相關性和嚴謹性。主要調查包括對檢查室管理人員、獸醫、採購負責人和行業高管進行結構化訪談，以了解實際操作、驗證預期和採購決定因素。從這些定性對話中獲得的見解有助於解讀技術採納模式以及影響最終用戶選擇的實際限制。次要調查包括對科學文獻、監管指南和產品文件進行系統性回顧，以檢驗檢測特性並確定每項技術的方法學優勢和局限性。

本文概述了綜合診斷創新、營運韌性和商業性可行性將如何決定獸醫免疫診斷領域未來的成功。

総括すると、獣医免疫診断分野では、技術革新と実用的な運用戦略を結びつけた統合的な対応が求められます。診断開発者は、分析的な卓越性を達成するだけでなく、檢查室や診療所のワークフローに適合し、種特有のニーズに対応し、地域の規制要件を満たす製品を設計しなければなりません。サプライヤーの多様化や地域に特化した製造アプローチを含む運用上のレジリエンスは、検査の継続性を維持し、集體爆發時の迅速な対応を支えるために不可欠です。商業性的な成功は、信頼性の高い供給、有意義なアフターサービス、そして臨床的效用を高めるデジタルツールを通じて、付加価値を提供できるかどうかにかかっています。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 獸用免疫診斷試劑市場：依產品類型分類

  • 免疫檢測盒
    • 化學冷光免疫檢測試劑盒
    • ELISA（酵素免疫分析法）試劑盒
    • 螢光免疫分析法盒
    • 橫向流動化驗試劑盒
    • 免疫測量（RIA）試劑盒
  • 裝置
    • 自動化免疫檢測系統
    • 化學冷光系統
    • 光度計
    • 微孔盤讀數儀
  • 試劑
    • 抗原/抗體
    • 緩衝液/溶液

第9章 獸用免疫診斷試劑市場：依技術分類

  • 化學冷光免疫檢測
  • ELISA
  • 流式細胞技術
  • 螢光免疫分析
  • 免疫組織化學（IHC）
  • 側向流動免疫檢測
  • 免疫測量（RIA）
  • 蛋白質印跡法

第10章 獸用免疫診斷市場：依動物類型分類

  • 水生動物
  • 伴侶動物
    • 狗
    • 貓
  • 家畜
    • 牛
    • 山羊
    • 家禽
    • 豬

第11章 獸用免疫診斷試劑市場：依通路分類

  • 離線
  • 線上

第12章 獸用免疫診斷試劑市場：依應用領域分類

  • 自體免疫疾病的診斷
  • 癌症診斷
  • 食品安全與品質檢驗
  • 荷爾蒙和代謝紊亂的診斷
  • 感染疾病診斷
  • 妊娠和生育能力測試
  • 毒素檢測

第13章 獸用免疫診斷試劑市場：依最終用戶分類

  • 診斷檢測實驗室
  • 製藥和生物技術公司
  • 研究機構
  • 獸醫醫院和獸醫診所

第14章 獸用免疫診斷試藥市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 獸用免疫診斷試劑市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 獸用免疫診斷試劑市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國獸用免疫診斷市場

第18章：中國獸用免疫診斷劑市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agrolabo SpA
  • Bio-Rad Laboratories, Inc.
  • BioChek BV
  • Biogal Galed Labs
  • bioMerieux SA
  • Bionote USA Inc.
  • Biopanda Reagents Ltd.
  • EIKEN CHEMICAL CO.,LTD
  • Elanco Animal Health
  • FUJIFILM Holdings Corporation
  • GD Animal Health
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Innovative Diagnostics SAS
  • LABOKLIN GMBH & CO. KG
  • Neogen Corporation
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • URIT Medical Electronic Co., Ltd.
  • Virbac Animal Health India Pvt. Ltd
  • VolitionRx Limited
  • Zoetis Inc.
Product Code: MRR-AD517FAA8B82

The Veterinary Immunodiagnostics Market was valued at USD 1.54 billion in 2025 and is projected to grow to USD 1.67 billion in 2026, with a CAGR of 8.51%, reaching USD 2.74 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.54 billion
Estimated Year [2026] USD 1.67 billion
Forecast Year [2032] USD 2.74 billion
CAGR (%) 8.51%

A comprehensive orientation to how technological innovation, clinical demand, and operational realities are converging to redefine veterinary immunodiagnostics

Veterinary immunodiagnostics stands at an inflection point where scientific advances and evolving clinical needs converge to reshape how diseases in animals are detected, managed, and prevented. Over the past decade, diagnostic platforms have moved from bespoke laboratory workflows toward more integrated, automated, and rapid-response systems that enable timely clinical decision-making across diverse care settings. As a result, veterinary practitioners, diagnostic laboratories, and research organizations increasingly consider immunodiagnostic solutions not merely as reagents and instruments but as components of broader health management ecosystems that include data analytics, point-of-care capabilities, and supply chain considerations.

This dynamic environment places a premium on adaptability. Stakeholders must reconcile the dual imperatives of technological innovation and operational reliability while navigating shifting regulatory frameworks and procurement practices. Therefore, executives need a clear line of sight into the prevailing diagnostic modalities, product form factors, and the end-user requirements that govern adoption. In addition, supply chain resilience, reagent quality, and interoperability with laboratory information systems have become decisive factors in purchasing decisions. Taken together, these forces necessitate a strategic approach that balances scientific rigor, commercial feasibility, and service delivery models to ensure diagnostic solutions meet the growing complexity of veterinary care.

How rapid assay innovation, workflow automation, and evolving distribution models are jointly reshaping the future of veterinary immunodiagnostics

The landscape of veterinary immunodiagnostics is undergoing transformative shifts driven by converging technological, clinical, and commercial trends. Rapid advances in assay chemistries and detection platforms have improved analytical sensitivity and throughput, enabling earlier and more accurate disease detection. At the same time, the rise of automation and integrated instrumentation has reduced hands-on time and variability, which in turn supports scaling diagnostic services from specialized labs to decentralized clinical settings. Consequently, product design is increasingly guided by the need for workflow efficiency, reproducibility, and compatibility with digital reporting systems.

Parallel to technological gains, clinical demand is expanding in scope and complexity. Practitioners across companion and livestock animal care settings require diagnostics that support preventive health, outbreak response, and food safety assurance. This shift places a premium on multiplexing capability and rapid turnaround, which allow veterinarians and producers to make evidence-based interventions. Moreover, regulatory landscapes and quality assurance expectations are maturing, prompting manufacturers to invest in validation, documentation, and post-market surveillance strategies that demonstrate clinical utility and reliability.

Commercial models are also evolving. Distribution channels now blend traditional offline relationships with growing online procurement pathways that emphasize convenience and quicker replenishment cycles. Strategic partnerships between diagnostics firms, pharmaceutical companies, and laboratory networks are intensifying, as firms seek to combine product portfolios with service delivery to capture greater value. Taken together, these transformative shifts underscore the need for integrated strategies that align product innovation with regulatory compliance, clinical applicability, and scalable distribution.

Operational and procurement consequences of United States tariff measures in 2025 and how industry participants are adapting sourcing and pricing strategies

United States tariff policies implemented in 2025 have introduced a recalibrated set of trade considerations that affect procurement, sourcing strategies, and cost structures within the veterinary immunodiagnostics supply chain. Manufacturers and distributors that rely on cross-border supply of instruments, reagents, and assay components have had to reassess vendor contracts, inventory policies, and supplier diversification to preserve continuity of service. As a result, procurement teams have accelerated supplier qualification processes and increased emphasis on multi-source frameworks to mitigate the risk of single points of failure.

In addition, the tariff environment has sharpened attention toward localized production capabilities and regional manufacturing partnerships. Stakeholders have responded by exploring nearshoring and dual-sourcing tactics that reduce exposure to import levies while preserving access to critical raw materials and specialized components. This operational realignment often requires upfront investments in supplier development and quality systems to ensure that alternative sources meet the validation standards required for diagnostic use. Furthermore, distributors and clinical end users have refined inventory management practices to buffer against episodic supply interruptions, with greater reliance on safety stock and predictive replenishment linked to clinical demand signals.

Importantly, the tariff-driven adjustments have also influenced strategic pricing and contracting approaches. Commercial teams are increasingly negotiating longer-term agreements that include clauses for duty mitigation and supply continuity, and manufacturers are exploring value-added service bundles to justify any price adjustments. Collectively, these responses reflect an industry-wide effort to maintain clinical access to essential immunodiagnostic tools while navigating the practical implications of updated trade measures.

Decoding product, technology, species, distribution, application, and end-user segmentation to inform prioritized product development and commercialization strategies

A nuanced understanding of segmentation reveals where product development and commercial efforts should concentrate to meet diverse clinical and operational needs. When the market is viewed through the lens of product type, three primary categories emerge: Immunoassay Kits, Instruments, and Reagents. Immunoassay Kits span chemiluminescent immunoassay kits, ELISA kits, fluorescence immunoassay kits, lateral flow assay kits, and radioimmunoassay kits, each addressing distinct use cases ranging from high-throughput laboratory testing to rapid point-of-care screening. Instruments include automated immunoassay systems, chemiluminescence systems, luminometers, and microplate readers, offering different balances of throughput, automation, and analytical capability. Reagents cover antigens and antibodies as well as buffers and solutions, which are foundational to assay performance and require consistent quality control.

Looking at technology, the market encompasses chemiluminescence immunoassays, ELISA, flow cytometry, fluorescence immunoassays, immunohistochemistry, lateral flow immunoassays, radioimmunoassay, and Western blotting. Each technology presents distinct strengths: some excel in sensitivity and quantitative output, while others offer rapid, equipment-free deployment suitable for field use. These technological distinctions drive decisions around validation pathways, end-user training, and laboratory integration.

Animal type introductions further refine product priorities. Aquatic animals, companion animals, and livestock animals exhibit different epidemiological profiles and testing requirements. Companion animal diagnostics often prioritize canine and feline applications with a focus on individualized care and preventive screening. Conversely, livestock diagnostics must support cattle, goats, poultry, and swine sectors where herd-level surveillance, rapid outbreak detection, and food safety implications shape product expectations.

Distribution channels bifurcate into offline and online pathways, and each route demands distinct service models. Offline channels traditionally emphasize field sales, technical support, and long-term supply relationships, whereas online procurement accelerates reorder cycles and supports standardized purchasing for institutional buyers. Applications span autoimmune disease diagnostics, cancer diagnostics, food safety and quality testing, hormonal and metabolic disorder diagnostics, infectious disease diagnostics, pregnancy and fertility testing, and toxin detection. These use cases dictate assay design, regulatory requirements, and clinical validation endpoints. Finally, end users include diagnostic laboratories, pharmaceutical and biotechnology companies, research institutes, and veterinary clinics and hospitals, each bringing unique operational constraints and procurement criteria that must be addressed through tailored product features and service offerings.

Taken together, segmentation insights highlight the importance of aligned product portfolios, validation strategies, and channel approaches that reflect the varied demands across technologies, animal types, and end-use contexts.

Regional competitiveness and differentiated demand across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape targeted market strategies and product localization

Regional dynamics present differentiated opportunities and operational considerations that should guide market entry and expansion strategies. In the Americas, well-established laboratory networks and a strong private veterinary sector drive demand for high-performance laboratory instruments and validated assay kits. This environment favors suppliers that offer robust technical support, regulatory alignment, and integrated service models that address both companion animal practices and large-scale livestock operations. In contrast, Europe, Middle East & Africa encompasses a wide spectrum of regulatory regimes and infrastructure capabilities. Here, market participants must navigate varied compliance requirements while designing solutions that are adaptable to both highly regulated markets and regions where laboratory capacity may be more limited. Strategic partnerships and regional distribution agreements often play a decisive role in achieving traction across this diverse geography.

Asia-Pacific presents a complex mix of rapid adoption and infrastructure heterogeneity. Several countries in the region have expanded veterinary services and food safety programs, creating demand for scalable diagnostics across both companion and livestock sectors. At the same time, local manufacturing capabilities and cost sensitivities influence procurement decisions, prompting multinational firms to consider manufacturing partnerships, licensing arrangements, and tailored product versions that meet regional price-performance expectations. Shifts in animal production systems, intensification of aquaculture, and heightened regulatory focus on feed and food safety further influence product priorities in this region. Across all geographies, logistics, regulatory harmonization efforts, and local technical support capabilities remain pivotal factors in determining successful deployment and sustained adoption.

Competitive landscape dynamics driven by portfolio depth, innovation velocity, strategic alliances, and value-added service models that determine market positioning and growth pathways

Competitive dynamics in veterinary immunodiagnostics combine the strengths of established multinational diagnostics firms with the agility of specialized innovators and the domain expertise of veterinary service providers. Leading organizations typically differentiate through comprehensive portfolios that pair instruments with validated assay kits and reliable reagent supplies, and they invest in quality assurance and regulatory compliance to support clinical adoption. In parallel, smaller, nimble companies specialize in point-of-care assays, novel chemistries, or unique species-specific diagnostics, often moving more quickly to validate innovative modalities and to serve niche applications.

Collaboration models are increasingly common. Commercial partnerships between instrument manufacturers and reagent suppliers create bundled solutions that reduce integration friction for laboratory and clinical buyers. Likewise, alliances with local distributors or service providers extend technical support capabilities into regions with diverse infrastructure. Competitive positioning also hinges on post-sale service, training, and digital tools that streamline result interpretation and reporting. These value-added services frequently determine adoption in markets where technical capacity varies. Lastly, firms that align product design with end-user workflows and regulatory requirements secure stronger uptake, as ease of use and confidence in analytical performance are central to purchasing decisions across both companion and production animal markets.

Practical strategic recommendations to fortify supply chains, align validation pathways, and expand commercial reach while accelerating technology adoption across diverse veterinary settings

Industry leaders should pursue a set of pragmatic actions to capture value and mitigate operational risk in a rapidly changing environment. First, prioritize investment in assay platforms and instrumentation that balance analytical performance with workflow efficiency, ensuring that products meet the needs of both centralized laboratories and decentralized clinical settings. To that end, aligning validation strategies with regulatory expectations and end-user use cases will accelerate clinical acceptance and integration into care pathways. Second, reinforce supply chain resilience through supplier diversification, regional manufacturing partnerships, and robust quality systems to reduce exposure to trade-related disruptions and to maintain steady reagent availability.

Third, expand commercial models to blend offline technical engagement with online procurement conveniences, thereby catering to institutional buyers and smaller clinical practices simultaneously. Complementary to distribution adaptations, cultivate strategic partnerships with laboratory networks, animal health services, and research organizations to co-develop applications and to validate clinical utility in real-world settings. Fourth, invest in digital tools and data analytics that enhance assay interpretation, facilitate surveillance, and enable predictive replenishment. Such digital capabilities not only improve clinical decision-making but also create recurring value streams that strengthen customer relationships.

Finally, adopt a regionally adaptive strategy that balances global standards with local customization. This includes tailoring product offerings to meet regional regulatory frameworks, cost sensitivities, and infrastructure realities. By implementing these actions in a coordinated manner, industry players can strengthen market resilience, accelerate adoption of advanced diagnostics, and better support animal health outcomes across species and geographies.

Transparent, multi-method research approach combining primary expert engagement, laboratory validation review, and systematic secondary analysis to ensure robust insights

This analysis synthesizes evidence through a transparent, multi-method research approach designed to ensure relevance and rigor. Primary research included structured interviews with laboratory directors, veterinary clinicians, procurement professionals, and industry executives to capture operational realities, validation expectations, and procurement drivers. These qualitative engagements informed the interpretation of technology adoption patterns and the practical constraints that shape end-user choices. Secondary research involved a systematic review of scientific literature, regulatory guidance, and product documentation to validate assay characteristics and to understand methodological strengths and limitations across technologies.

Where feasible, laboratory-level validation studies and technical performance data were reviewed to corroborate claims regarding sensitivity, specificity, and workflow integration. Supply chain assessments drew upon publicly available trade data and industry disclosures to identify key sourcing dependencies and logistical constraints. Throughout the process, findings were triangulated across multiple sources to mitigate bias and to ensure that conclusions reflect both scientific evidence and market realities. Methodological transparency and source traceability undergird the analysis, enabling stakeholders to evaluate the applicability of insights to their specific organizational contexts.

Concluding synthesis of how integrated diagnostic innovation, operational resilience, and commercial execution together determine future success in veterinary immunodiagnostics

In synthesis, veterinary immunodiagnostics requires an integrated response that couples technological innovation with practical operational strategies. Diagnostic developers must design products that not only achieve analytical excellence but also fit into the workflows of laboratories and clinics, accommodate species-specific needs, and meet regional regulatory expectations. Operational resilience, including supplier diversification and targeted regional manufacturing approaches, is essential to preserve continuity of testing and to support rapid response in outbreak scenarios. Commercial success will hinge on the ability to offer bundled value through reliable supply, meaningful post-sale service, and digital tools that enhance clinical utility.

Looking forward, stakeholders that align product development with real-world use cases, invest in robust validation and quality systems, and adopt adaptive distribution models will be best positioned to support animal health outcomes across companion, production, and aquatic sectors. By synthesizing the technological, regulatory, and commercial dimensions of the market, organizations can craft strategies that deliver both clinical impact and sustainable commercial returns.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Immunodiagnostics Market, by Product Type

  • 8.1. Immunoassay Kits
    • 8.1.1. Chemiluminescent Immunoassay Kits
    • 8.1.2. ELISA (Enzyme-Linked Immunosorbent Assay) Kits
    • 8.1.3. Fluorescence Immunoassay Kits
    • 8.1.4. Lateral Flow Assay Kits
    • 8.1.5. Radioimmunoassay (RIA) Kits
  • 8.2. Instruments
    • 8.2.1. Automated Immunoassay Systems
    • 8.2.2. Chemiluminescence Systems
    • 8.2.3. Luminometers
    • 8.2.4. Microplate Readers
  • 8.3. Reagents
    • 8.3.1. Antigens & Antibodies
    • 8.3.2. Buffers & Solutions

9. Veterinary Immunodiagnostics Market, by Technology

  • 9.1. Chemiluminescence Immunoassays
  • 9.2. ELISA
  • 9.3. Flow Cytometry
  • 9.4. Fluorescence Immunoassays
  • 9.5. Immunohistochemistry (IHC)
  • 9.6. Lateral Flow Immunoassays
  • 9.7. Radioimmunoassay (RIA)
  • 9.8. Western Blotting

10. Veterinary Immunodiagnostics Market, by Animal Type

  • 10.1. Aquatic Animals
  • 10.2. Companion Animals
    • 10.2.1. Canine
    • 10.2.2. Feline
  • 10.3. Livestock Animals
    • 10.3.1. Cattle
    • 10.3.2. Goats
    • 10.3.3. Poultry
    • 10.3.4. Swine

11. Veterinary Immunodiagnostics Market, by Distribution Channel

  • 11.1. Offline
  • 11.2. Online

12. Veterinary Immunodiagnostics Market, by Application

  • 12.1. Autoimmune Disease Diagnostics
  • 12.2. Cancer Diagnostics
  • 12.3. Food Safety & Quality Testing
  • 12.4. Hormonal & Metabolic Disorder Diagnostics
  • 12.5. Infectious Disease Diagnostics
  • 12.6. Pregnancy & Fertility Testing
  • 12.7. Toxin Detection

13. Veterinary Immunodiagnostics Market, by End User

  • 13.1. Diagnostic Laboratories
  • 13.2. Pharmaceutical & Biotechnology Companies
  • 13.3. Research Institutes
  • 13.4. Veterinary Clinics & Hospitals

14. Veterinary Immunodiagnostics Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Veterinary Immunodiagnostics Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Veterinary Immunodiagnostics Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Veterinary Immunodiagnostics Market

18. China Veterinary Immunodiagnostics Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Agrolabo S.p.A.
  • 19.6. Bio-Rad Laboratories, Inc.
  • 19.7. BioChek BV
  • 19.8. Biogal Galed Labs
  • 19.9. bioMerieux SA
  • 19.10. Bionote USA Inc.
  • 19.11. Biopanda Reagents Ltd.
  • 19.12. EIKEN CHEMICAL CO.,LTD
  • 19.13. Elanco Animal Health
  • 19.14. FUJIFILM Holdings Corporation
  • 19.15. GD Animal Health
  • 19.16. Heska Corporation
  • 19.17. IDEXX Laboratories, Inc.
  • 19.18. INDICAL BIOSCIENCE GmbH
  • 19.19. Innovative Diagnostics SAS
  • 19.20. LABOKLIN GMBH & CO. KG
  • 19.21. Neogen Corporation
  • 19.22. QIAGEN N.V.
  • 19.23. Randox Laboratories Ltd.
  • 19.24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 19.25. Thermo Fisher Scientific Inc.
  • 19.26. URIT Medical Electronic Co., Ltd.
  • 19.27. Virbac Animal Health India Pvt. Ltd
  • 19.28. VolitionRx Limited
  • 19.29. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA) KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOMATED IMMUNOASSAY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LUMINOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY MICROPLATE READERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANTIGENS & ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY BUFFERS & SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FLUORESCENCE IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY (IHC), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LATERAL FLOW IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RADIOIMMUNOASSAY (RIA), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY WESTERN BLOTTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FELINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GOATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY CANCER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY FOOD SAFETY & QUALITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY HORMONAL & METABOLIC DISORDER DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TOXIN DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY VETERINARY CLINICS & HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 258. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 259. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 260. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 261. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 263. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 264. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 265. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. GCC VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY LIVESTOCK ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 291. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 292. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY KITS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 VETERINARY IMMUNODIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 295. G7 VETERINARY IMMUNO